Your browser doesn't support javascript.
loading
Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome.
Vanlander, A V; Jorens, P G; Smet, J; De Paepe, B; Verbrugghe, W; Van den Eynden, G G; Meire, F; Pauwels, P; Van der Aa, N; Seneca, S; Lissens, W; Okun, J G; Van Coster, R.
Affiliation
  • Vanlander AV; Department of Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium.
Acta Anaesthesiol Scand ; 56(4): 520-5, 2012 Apr.
Article in En | MEDLINE | ID: mdl-22260353
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxidative Phosphorylation / Propofol / Anesthetics, Intravenous / Optic Atrophy, Hereditary, Leber Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Acta Anaesthesiol Scand Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxidative Phosphorylation / Propofol / Anesthetics, Intravenous / Optic Atrophy, Hereditary, Leber Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Humans / Male Language: En Journal: Acta Anaesthesiol Scand Year: 2012 Document type: Article Affiliation country: Country of publication: